BF Biosciences Limited (BFBIO) announcements
Everything BF Biosciences Limited has filed with the Pakistan Stock Exchange, newest first: financial results, insider trades, material information and notices.
- NoticeTransmission of Quarterly Financial Statements for the Period Ended 30-09-2026
- NoticeCertified true copy of the resolutions passed in the Annual General Meeting of the Company
- NoticeAnnual Progress Report for the Year Ended June 30, 2026
- Financial resultBF Biosciences Limited reported a net profit of Rs 184.88 million for the first quarter ended 30 September 2026Filed as: Financial Results for the Quarter Ended 30-09-2026
- NoticeBoard Meeting
- NoticeTransmission of Annual Financial Statements for the Year Ended 30-06-2026
- NoticeNotice of Annual General Meeting
- NoticeNotice of Annual General Meeting prior to publication
- Financial resultBF Biosciences Limited reported a strong financial performance for the year ended 30 June 2026Filed as: Financial Results for the Year Ended 2026-06-30
- NoticeBoard Meeting
- Material informationBF Biosciences Launches CGM Devices in PakistanBF Biosciences, in collaboration with SIBIONICS, launches Sibionics CGM devices in Pakistan, enhancing diabetes management solutions.
- NoticeApproval of Annual Budget for FY 2026-27
- NoticeBoard Meeting Other Than Financial Results
- NoticeAppointment of Director to Fill Casual Vacancy
- NoticeIntimation of Passing Away of Mrs. Akhter Khalid Waheed, Director and Founding CEO
- NoticeAppointment of Director to Fill Casual Vacancy
- Financial resultBF Biosciences Limited reported a strong financial performance for the nine months ended 31 March 2026Filed as: Financial Results for the Quarter Ended 31-03-2026
- Financial resultBFBIO demonstrated solid growth with a revenue increase to Rs 2.67 billion, while profit after taxation rose to Rs 187.78 millionFiled as: Financial Results for the Quarter Ended 31-12-2025
Showing the latest 18. Source: company filings on the Pakistan Stock Exchange. Summaries are written from the filings by software and can contain errors; the filing itself is the record. Investing in securities involves risk, including possible loss of principal.